rs80356776
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_001876.4(CPT1A):c.941C>T(p.Thr314Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,459,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001876.4 missense
Scores
Clinical Significance
Conservation
Publications
- carnitine palmitoyl transferase 1A deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CPT1A | NM_001876.4 | c.941C>T | p.Thr314Ile | missense_variant | Exon 9 of 19 | ENST00000265641.10 | NP_001867.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459600Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 4AN XY: 725922 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Carnitine palmitoyl transferase 1A deficiency Pathogenic:2Other:1
Variant summary: CPT1A c.941C>T (p.Thr314Ile) results in a non-conservative amino acid change located in the Choline/Carnitine o-acyltransferase domain (IPR039551) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 248962 control chromosomes. c.941C>T has been reported in the homozygous state in the literature in at least 1 individual affected with Carnitine Palmitoyltransferase I Deficiency (example, Stoler_2004). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in complete loss of any detectable enzyme activity in patient fibroblasts (Stoler_2004). The following publication has been ascertained in the context of this evaluation (PMID: 15669684). ClinVar contains an entry for this variant (Variation ID: 65657). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at